Imidazole-4-lactic Acid, (S)-2-hydroxy-3-(1(3)H-imidazol-4-yl)-propionic acid - Names and Identifiers
Name | L-B-imidazolelactic acid
|
Synonyms | L-B-imidazolelactic acid L-BETA-IMIDAZOLELACTIC ACID IMIDAZOLE-4-LACTIC ACID, MONOHYDRATE L-beta-(1H-imidazol-4-yl)lactic acid L-B-IMIDAZOLELACTIC ACID, MONOHYDRATE 2-HYDROXY-3-(4-IMIDAZOLYL)PROPANOIC ACID 2-HYDROXY-3-[4-IMIDAZOYL]-PROPANOIC ACID α-hydroxy-1H-Imidazole-4(5)-propanoicacid (S)-2-HYDROXY-3-(1(3)H-IMIDAZOL-4-YL)-PROPIONIC ACID Imidazole-4-lactic Acid, (S)-2-hydroxy-3-(1(3)H-imidazol-4-yl)-propionic acid
|
CAS | 14403-45-3
|
InChI | InChI=1/C6H8N2O3/c9-5(6(10)11)1-4-2-7-3-8-4/h2-3,5,9H,1H2,(H,7,8)(H,10,11)/t5-/m0/s1 |
Imidazole-4-lactic Acid, (S)-2-hydroxy-3-(1(3)H-imidazol-4-yl)-propionic acid - Physico-chemical Properties
Molecular Formula | C6H8N2O3
|
Molar Mass | 156.14 |
Density | 1.518±0.06 g/cm3(Predicted) |
Melting Point | 195-198°C |
Boling Point | 507.7±35.0 °C(Predicted) |
Flash Point | 260.9°C |
Vapor Presure | 3.93E-11mmHg at 25°C |
pKa | 3.48±0.11(Predicted) |
Storage Condition | Sealed in dry,2-8°C |
Refractive Index | 1.617 |
Imidazole-4-lactic Acid, (S)-2-hydroxy-3-(1(3)H-imidazol-4-yl)-propionic acid - Risk and Safety
Hazard Symbols | Xi - Irritant
|
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin.
|
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36 - Wear suitable protective clothing.
|
WGK Germany | 3 |
Imidazole-4-lactic Acid, (S)-2-hydroxy-3-(1(3)H-imidazol-4-yl)-propionic acid - Introduction
L-B-imidazolelactic acid (abbreviated HIPEC) is an organic compound that has the following properties:
Nature:
-Appearance: White crystalline solid
-Melting point: About 110-118 ° C
-Solubility: Soluble in water and ethanol, insoluble in non-polar solvents
Use:
- HIPEC can be used as a biocatalyst to participate in asymmetric synthesis reactions in organic synthesis.
-It can also be used as a pharmaceutical intermediate for the synthesis of biologically active organic compounds.
Method:
-A common preparation method is to obtain L-B-imidazolelactic acid through the hydrogenation reaction of imidazole and (S)-3-hydroxypropylcyanoacetic acid.
Safety Information:
-The safety assessment of HIPEC is limited, so it is necessary to follow appropriate safety procedures when using it.
-Be aware of toxicity and irritation, contact with skin, eyes or respiratory tract may cause adverse reactions.
-Wear protective gloves, goggles and respiratory protection during use to ensure operation in a well-ventilated area.
-In case of accidental exposure or ingestion, seek medical attention immediately and provide relevant materials for diagnosis and treatment.
Last Update:2024-04-09 20:49:11